Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects

Critical Care Medicine

Volumn 28, Issue 1, 2000, Pages 240-244

  Richards, Guy A ^a,f   Murphy, Sandy ^a   Jobson, Reeve ^b   Mer, Mervyn ^a   Zinman, Caron ^a   Taylor, Ruth ^a   Swanepoel, Robert ^c   Duse, Adrian ^d   Sharp, Gerry ^a   De La Rey, Ina C J ^g   Kassianides, Chris ^e  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Sandton Clinic   (South Africa)

^c National Institute for Virology   (Australia)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e Morningside Clinic   (South Africa)

^f UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^g Medical School ^*

Author keywords

Ebola; Hemorrhagic fever; Infection control

Indexed keywords

ALPHA2B INTERFERON; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR; HYDROCORTISONE; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; NUCLEOTIDE; OXYGEN; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; IMMUNOFLUORESCENCE; INFECTION CONTROL; MALE; PRIORITY JOURNAL; VIRUS GENE; VIRUS HEMORRHAGIC FEVER;

EID: 0033950887     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200001000-00041     Document Type: Article

References (22)

1. 1. Georges-Courbot M-C, Sanchez A, Lu C-Y, et al: Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis 1997; 3:59-62
2. 2. Swanepoel R: Viral hemorrhagic fevers in South Africa: History and national strategy. S Afr J Sci 1987; 83:80-88
3. 3. Georges-Courbot M-C, Lu C-Y, Lansout-Soukate J, et al: Isolation and molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon. Lancet 1997; 349:181
4. 4. Peters CJ: Pathogenesis of viral hemorrhagic fevers. In: Viral Pathogenesis. Nathanson N (Ed). Philadelphia, Lippincott-Raven, 1995, pp 779-800
5. 5. Swanepoel R, Shepherd AJ, Leman PA, et al: Epidemiologic and clinical features of Crimean-Congo hemorrhagic fevers in southern Africa. Am J Trop Med Hyg 1987; 30:120-132
6. 6. McCormick JB, Fisher Hoch SP: Filoviruses. In: Kass Handbook of Infectious Diseases. Exotic Viral Infections. Porterfield JS (Ed). London, Chapman and Hall, 1995, pp 319-328
7. 7. Feldman H, Bugary H, Mahner F, et al: Virus-induced endothelial permeability triggered by affected macrophages. Abstr. FASEB J 1994; 8:A756
8. 8. Baskerville A, Fischer-Hoch SP, Neild GH, et al: Ultrastructural pathology of experimental Ebola hemorrhagic fever virus infection. J Pathol 1985; 147:199-209
9. 9. Feldman H, Nicol ST, Klenk H-D, et al: Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 1994; 199:469-473
10. 10. Peters CJ, Sanchez A, Feldmann H, et al: Filoviruses as emerging pathogens. Semin Virol 1994; 5:147-154
11. 11. Swanepoel R, Gill DE, Shepherd AJ, et al: The clinical pathology of Crimean Congo hemorrhagic fever. Rev Infect Dis 1989; 11(Suppl 4):S794-S800
12. 12. Molinas FC, de Bracco MM, Maiztegui JI: Hemostasis and the complement system in Argentine hemorrhagic fever. Rev Infect Dis 1989; 11(Suppl 4):S762-S767
13. 13. Entwisle G, Hale E: Hemodynamic alterations in hemorrhagic fevers. Circulation 1957; 15:414-425
14. 14. Duchin JS, Koster F, Peters CJ, et al: Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994; 330:949-955
15. 15. Qian C, Jarhling PB, Peters CJ, et al: Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. Lab Anim Sci 1994; 44:600-607
16. 16. Van Eeden PJ, Van Eeden SF, Joubert JR, et al: A nosocomial outbreak of Crimean Congo haemorrhagic fever at Tygerberg Hospital, part II: Management of patients. S Afr Med J 1985; 68:718-721
17. 17. McCormick JB, King IJ, Webb PA, et al: Lassa fever: Effective therapy with ribavirin. N Engl J Med 1986; 314:20-26
18. 18. Swanepoel R: Nairovirus infections. In: Kass Handbook of Infectious Diseases: Exotic Viral Infections. Porterfield JS (Ed). London, Chapman and Hall, 1995, pp 285-293
19. 19. Fisher-Hoch SP, Khan JA, Rehman S, et al: Crimean-Congo hemorrhagic fever treated with oral ribavirin. Lancet 1995; 346: 472-475
20. 20. Centers for Disease Control: Recommendations for prevention for HIV transmission in health care settings. MMWR Morb Mortal Wkly Rep 1987; 36(Suppl 2S):1-18.
21. 21. Gear JS, Cassel GA, Gear AJ, et al: Outbreak of Marburg virus disease in Johannesburg. BMJ 1975; 4:489-493
22. 22. Joubert JR, King JB, Roussouw DJ, et al: A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital, part III: Clinical pathology and pathogenesis. S Afr Med J 1985; 68:722-728.